KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

West Pharmaceutical Services (WST) Receivables - Other (2017 - 2026)

West Pharmaceutical Services has reported Receivables - Other over the past 10 years, most recently at $15.4 million for Q1 2026.

  • Quarterly Receivables - Other fell 40.31% to $15.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $15.4 million through Mar 2026, down 40.31% year-over-year, with the annual reading at $11.9 million for FY2025, 48.93% down from the prior year.
  • Receivables - Other was $15.4 million for Q1 2026 at West Pharmaceutical Services, up from $11.9 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $42.3 million in Q3 2024 and troughed at $11.9 million in Q4 2025.
  • The 5-year median for Receivables - Other is $19.9 million (2023), against an average of $21.4 million.
  • Biggest five-year swings in Receivables - Other: surged 112.56% in 2024 and later tumbled 48.93% in 2025.
  • Tracing WST's Receivables - Other over 5 years: stood at $16.3 million in 2022, then skyrocketed by 31.9% to $21.5 million in 2023, then grew by 8.37% to $23.3 million in 2024, then tumbled by 48.93% to $11.9 million in 2025, then increased by 29.41% to $15.4 million in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $15.4 million, $11.9 million, and $27.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.